NCT04631198 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Cavenaghi S, Ferreira LL, Marino LH, Lamari NM
Respiratory physiotherapy in the pre and postoperative myocardial revascularization surgery. Rev Bras Cir Cardiovasc. 2011 Jul-Sep;26(3):455-61. doi: 10.5935/1678-9741.20110022. English, Portuguese.
Cordeiro AM, Souza DC, Quinzani RH, Troster EJ
[Comparison between an upper airway obstruction score and airway endoscopy to detect airway injury associated with endotracheal intubation in children]. J Pediatr (Rio J). 2003 Nov-Dec;79(6):543-9. Portuguese.
Hulzebos EH, Van Meeteren NL, De Bie RA, Dagnelie PC, Helders PJ
Prediction of postoperative pulmonary complications on the basis of preoperative risk factors in patients who had undergone coronary artery bypass graft surgery. Phys Ther. 2003 Jan;83(1):8-16.

Comparison of the Effects of Conventional Physiotherapy Versus Thoracoabdominal Rebalancing in Reducing Respiratory Complications in Post-operative Patients of Myocardial Revascularization Surgery

Details for clinical trial NCT04631198

Clinical trial NCT04631198 - References